How to Better Regulate Payments to Research Participants

The development of life-saving drugs and cutting-edge treatments depends on people participating in clinical research. But federal regulators restrict clinical researchers from using the exchange of payments for research participation—a powerful study recruitment strategy—because they worry that this practice leads to coercion or undue inducement. Because of the regulatory limits on payments in clinical research, Institutional Review Boards (IRBs)—the committees in charge of evaluating the ethics of research proposals—often block researchers from paying prospective research participants, which inhibits their ability to move forward with projects. To speed the pace of research development and innovation, regulators must revisit their definitions of coercion and undue inducement, as well as encourage the use of financial incentives for research recruitment, assert Emily Largent and Holly Fernandez Lynch, professors at the Perelman School of Medicine at the…

Read more detail on Recent Administrative Law posts –

This entry was posted in Administrative law and tagged , , , , . Bookmark the permalink.

Leave a Reply